Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (21-30 of 315) with videos related to

Pageof 32
Sort By:
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancerZulfiqar Malik, Cathy Eng
Journal of the National Cancer Institute|August 18, 2021
Early-Onset Colorectal Cancer: The Mystery RemainsCathy Eng, Howard Hochster
The Lancet. Gastroenterology & Hepatology|August 3, 2019
More questions regarding HIPEC in colorectal carcinomatosisBenny Johnson, Cathy Eng
Expert Opinion on Pharmacotherapy|June 30, 2006
Biological agents versus chemotherapy in the treatment of colorectal cancerCathy Eng, Nabeel Shalan
Journal of Oncology Practice|September 22, 2010
Commentary: practice patterns and potential impact on quality measures for a practicing physicianCathy Eng, Scott Kopetz
Current Treatment Options in Oncology|July 11, 2014
Optimal treatment strategies for anal cancerShahab Ahmed, Cathy Eng
Clinical Colorectal Cancer|February 19, 2008
Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastasesAchala Bhaskara, Cathy Eng
Cancer Treatment and Research|March 7, 2003
Epidemiology, staging, and screening of head and neck cancerAthanassios Argiris, Cathy Eng
Current Treatment Options in Oncology|May 30, 2009
Treatment options in metastatic squamous cell carcinoma of the anal canalCathy Eng, Priyanka Pathak
Current Oncology Reports|January 25, 2018
Role of Chemotherapy in the Neoadjuvant/Adjuvant Setting for Patients With Rectal Adenocarcinoma Undergoing Chemoradiotherapy and Surgery or Radiotherapy and SurgeryShahab Ahmed, Cathy Eng
Pageof 32

Showing results (21-30 of 315) with videos related to

Sort By:
Pageof 32
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancerZulfiqar Malik, Cathy Eng
Journal of the National Cancer Institute|August 18, 2021
Early-Onset Colorectal Cancer: The Mystery RemainsCathy Eng, Howard Hochster
The Lancet. Gastroenterology & Hepatology|August 3, 2019
More questions regarding HIPEC in colorectal carcinomatosisBenny Johnson, Cathy Eng
Expert Opinion on Pharmacotherapy|June 30, 2006
Biological agents versus chemotherapy in the treatment of colorectal cancerCathy Eng, Nabeel Shalan
Journal of Oncology Practice|September 22, 2010
Commentary: practice patterns and potential impact on quality measures for a practicing physicianCathy Eng, Scott Kopetz
Current Treatment Options in Oncology|July 11, 2014
Optimal treatment strategies for anal cancerShahab Ahmed, Cathy Eng
Clinical Colorectal Cancer|February 19, 2008
Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastasesAchala Bhaskara, Cathy Eng
Cancer Treatment and Research|March 7, 2003
Epidemiology, staging, and screening of head and neck cancerAthanassios Argiris, Cathy Eng
Current Treatment Options in Oncology|May 30, 2009
Treatment options in metastatic squamous cell carcinoma of the anal canalCathy Eng, Priyanka Pathak
Current Oncology Reports|January 25, 2018
Role of Chemotherapy in the Neoadjuvant/Adjuvant Setting for Patients With Rectal Adenocarcinoma Undergoing Chemoradiotherapy and Surgery or Radiotherapy and SurgeryShahab Ahmed, Cathy Eng
Pageof 32